Breaking News Instant updates and real-time market news.

MKGAY

Merck KGaA

$36.20

0.32 (0.89%)

, PFE

Pfizer

$33.23

-0.38 (-1.13%)

12:02
10/11/16
10/11
12:02
10/11/16
12:02

Transgene collaborates with Merck KGaA, Darmstadt, Pfizer on HPV study

Transgene announced it has entered a collaboration agreement with the science and technology company Merck KGaA (MKGAY), Darmstadt, Germany, and Pfizer (PFE) under which Transgene will sponsor a Phase 1/2 study evaluating the potential of the therapeutic vaccine candidate TG4001 in combination with avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, for the treatment of human papilloma virus-positive head and neck squamous cell carcinoma, after failure of standard therapy. Philippe Archinard, Chairman and CEO of Transgene, commented: "We are pleased to enter this collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate our therapeutic vaccine TG4001 in association with avelumab. In previous clinical trials, TG4001 has demonstrated promising activity in terms of HPV viral clearance and was well tolerated. TG4001 is one of the few drugs targeting HPV-associated cancers that can be combined with an immune checkpoint blocker such as avelumab. The preclinical and clinical data that have been generated with both TG4001 and avelumab individually suggest this combination could potentially demonstrate a synergistic effect, delivering a step up in therapy for HPV-positive HNSCC patients." The combination of TG4001 and avelumab aims to target two distinct steps in the immune response to target cancer cells. This is an exclusive agreement between the parties to study the combination of these two classes of investigational agents in HPV-positive HNSCC.

MKGAY

Merck KGaA

$36.20

0.32 (0.89%)

PFE

Pfizer

$33.23

-0.38 (-1.13%)

  • 01

    Nov

MKGAY Merck KGaA
$36.20

0.32 (0.89%)

08/12/16
BREN
08/12/16
DOWNGRADE
BREN
Hold
Merck KGaA downgraded to Hold from Buy at Berenberg
PFE Pfizer
$33.23

-0.38 (-1.13%)

08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Pfizer acquisition 'a good fit strategically,' says Piper Jaffray
After Pfizer (PFE) agreed to buy Medivation (MDVN), Piper Jaffray analyst Richard Purkiss says that Pfizer has obtained Xtandi, "a blockbuster prostate cancer treatment," and "a close-to-market and late-stage pipeline." The analyst thinks that Xtandi's expansion to use in adjuvant prostate cancer could increase its sales by 65%-70%. He keeps a $54 price target and Overweight rating on Pfizer.
08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.

TODAY'S FREE FLY STORIES

WYNN

Wynn Resorts

$118.22

2.65 (2.29%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Hot Stocks
Wynn Resorts reports Q1 Macau revenues down 3.5% to $587M »

Reports Macau Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NUVA

NuVasive

$76.94

0.59 (0.77%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Earnings
NuVasive sees FY17 non-GAAP EPS $2.00, consensus $2.02 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 18

    May

PNRA

Panera Bread

$313.72

-0.35 (-0.11%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Earnings
Panera Bread reports Q1 EPS $1.83, consensus $1.84 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SD

SandRidge Energy

$18.80

0.28 (1.51%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Initiation
SandRidge Energy initiated  »

SandRidge Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

CMG

Chipotle

$471.33

2.539 (0.54%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Earnings
Chipotle backs FY17 SSS view of up in high-single digits »

Backs FY17 restaurant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$181.50

1.3 (0.72%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Illumina sees Q2 adjusted EPS 65c-70c, consensus 87c »

Sees Q2 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GPRO

GoPro

$9.18

0.17 (1.89%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Hot Stocks
GoPro says Susan Lyne joins board of directors »

GoPro announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 24

    May

  • 25

    May

CENX

Century Aluminum

$13.62

0.99 (7.84%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Century Aluminum reports Q1 EPS (5c), consensus (17c) »

Reports adjusted EBITDA1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NUVA

NuVasive

$76.94

0.59 (0.77%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
NuVasive reports Q1 non-GAAP EPS 38c, consensus 38c »

Reports Q1 revenue $250M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 18

    May

CMG

Chipotle

$471.15

2.36 (0.50%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Hot Stocks
Chipotle reports Q1 EPS $1.60, consensus $1.27 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$181.50

1.3 (0.72%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Illumina sees FY17 adjusted EPS $3.60-$3.70, consensus $3.64 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DDR

DDR Corp.

$12.40

0.185 (1.52%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
DDR Corp. reports Q1 EPS (16c), may not compare to consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ALGT

Allegiant Travel

$163.85

-1.2 (-0.73%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Allegiant sees Q2 TRASM increasing 1.5%-3.5% vs. Q2 last year »

Sees Q2 CASM ex fuel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Shutterfly sees 2017 EPS 45c-80c, consensus 59c »

Sees 2017 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

WYNN

Wynn Resorts

$118.22

2.65 (2.29%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Wynn Resorts reports Q1 EPS $1.24, consensus 96c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

PRGO

Perrigo

$67.80

0.745 (1.11%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Hot Stocks
Perrigo concludes some previous financial statements should not be relied upon »

Perrigo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Shutterfly sees Q2 EPS (55c)-(50c), consensus (49c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

RNG

RingCentral

$30.68

0.475 (1.57%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Hot Stocks
RingCentral CFO Clyde Hosein to leave company at end of May 2017 »

RingCentral announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 30

    May

ILMN

Illumina

$181.50

1.3 (0.72%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Illumina reports Q1 adjusted EPS 64c, consensus 64c »

Reports Q1 revenue $598M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
Shutterfly reports Q1 EPS (98c), consensus (99c) »

Reports Q1 revenue $192M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

EQGP

EQT GP

$27.22

-0.34 (-1.23%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Hot Stocks
EQT GP raises quarterly distribution to 19.1c per unit »

EQT GP Holdings declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

RNG

RingCentral

$30.68

0.475 (1.57%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
RingCentral reports Q1 adjusted EPS 3c, consensus 2c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 30

    May

ALGT

Allegiant Travel

$163.85

-1.2 (-0.73%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
Allegiant Travel reports Q1 EPS $2.50, consensus $2.67 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

PRGO

Perrigo

$67.80

0.75 (1.12%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
Perrigo sees FY17 ex-items revenue $4.6B-$4.8B, consensus $5.47B »

The Company is issuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$79.00

1.22 (1.57%)

16:08
04/25/17
04/25
16:08
04/25/17
16:08
Hot Stocks
EQT Midstream Partners raises quarterly distribution to 89c per unit »

EQT Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.